▶ 調査レポート

神経障害性疼痛管理の世界市場 2019年版:種類別(三環系抗うつ薬、抗けいれん薬、オピオイド、ステロイド薬、局所麻酔、その他)、用途別(小売薬局、病院薬局、その他)

• 英文タイトル:Global Neuropathic Pain Management Market 2019 by Company, Regions, Type and Application, Forecast to 2024

GlobalInfoResearchが調査・発行した産業分析レポートです。神経障害性疼痛管理の世界市場 2019年版:種類別(三環系抗うつ薬、抗けいれん薬、オピオイド、ステロイド薬、局所麻酔、その他)、用途別(小売薬局、病院薬局、その他) / Global Neuropathic Pain Management Market 2019 by Company, Regions, Type and Application, Forecast to 2024 / C-GIR20G2898資料のイメージです。• レポートコード:C-GIR20G2898
• 出版社/出版日:GlobalInfoResearch / 2019年12月30日
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、106ページ
• 納品方法:Eメール
• 産業分類:医療
• 販売価格(消費税別)
  Single User¥515,040 (USD3,480)▷ お問い合わせ
  Multi User¥772,560 (USD5,220)▷ お問い合わせ
  Corporate User¥1,030,080 (USD6,960)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
「神経障害性疼痛管理の世界市場2019年」は、グローバルにおける神経障害性疼痛管理市場を展望するレポートです。神経障害性疼痛管理のグローバル市場概観、企業動向、企業別シェア、市場規模推移、市場規模予測(2019年-2024年)、主要地域分析(北米、ヨーロッパ、アジア等)、主要国分析(日本、中国、アメリカ等)データなどを掲載しています。
・神経障害性疼痛管理の市場概観
・神経障害性疼痛管理の企業概要(事業概要、製品種類、販売量、価格、売上、市場シェア等)
・神経障害性疼痛管理の企業別販売動向、市場シェア、市場集中度、競争動向
・神経障害性疼痛管理の世界市場規模
・神経障害性疼痛管理の北米市場分析(アメリカ、カナダ、メキシコ等)
・神経障害性疼痛管理のアメリカ市場規模推移
・神経障害性疼痛管理のカナダ市場規模推移
・神経障害性疼痛管理のメキシコ市場規模推移
・神経障害性疼痛管理のヨーロッパ市場分析(ドイツ、イギリス、ロシア、フランス、イタリア等)
・神経障害性疼痛管理のドイツ市場規模推移
・神経障害性疼痛管理のイギリス市場規模推移
・神経障害性疼痛管理のロシア市場規模推移
・神経障害性疼痛管理のアジア太平洋市場分析(日本、中国、韓国、インド、東南アジア等)
・神経障害性疼痛管理の日本市場規模推移
・神経障害性疼痛管理の中国市場規模推移
・神経障害性疼痛管理の韓国市場規模推移
・神経障害性疼痛管理のインド市場規模推移
・神経障害性疼痛管理の東南アジア市場規模推移
・神経障害性疼痛管理の南米市場分析(ブラジル、アルゼンチン等)
・神経障害性疼痛管理の中東・アフリカ市場分析(サウジアラビア、UAE、南アフリカ等)
・神経障害性疼痛管理の種類別分析/販売量、売上、市場シェア(三環系抗うつ薬、抗けいれん薬、オピオイド、ステロイド薬、局所麻酔、その他)
・神経障害性疼痛管理の用途別分析/市場規模(小売薬局、病院薬局、その他)
・神経障害性疼痛管理の市場予測2019年-2024年(地域別予測、種類別予測、用途別予測)
・神経障害性疼痛管理の販売チャネル・代理店・貿易業者・ディーラー分析

Scope of the Report:
The global Neuropathic Pain Management market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Neuropathic Pain Management.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Neuropathic Pain Management market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Neuropathic Pain Management market by product type and applications/end industries.

Market Segment by Companies, this report covers
Biogen Idec
Baxter Healthcare Corporation
GlaxoSmithKline
Johnson & Johnson Services
Pfizer
Sanofi
Bristol-Myers Squibb
Eli Lilly and Company
Depomed

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Tricyclic Antidepressant
Anticonvulsant
Opioid
Steroid Drug
Local Anesthesia
Other

Market Segment by Applications, can be divided into
Retail Pharmacy
Hospital Pharmacy
Other

レポート目次

Table of Contents

1 Neuropathic Pain Management Market Overview
1.1 Product Overview and Scope of Neuropathic Pain Management
1.2 Classification of Neuropathic Pain Management by Types
1.2.1 Global Neuropathic Pain Management Revenue Comparison by Types (2019-2024)
1.2.2 Global Neuropathic Pain Management Revenue Market Share by Types in 2018
1.2.3 Tricyclic Antidepressant
1.2.4 Anticonvulsant
1.2.5 Opioid
1.2.6 Steroid Drug
1.2.7 Local Anesthesia
1.2.8 Other
1.3 Global Neuropathic Pain Management Market by Application
1.3.1 Global Neuropathic Pain Management Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Retail Pharmacy
1.3.3 Hospital Pharmacy
1.3.4 Other
1.4 Global Neuropathic Pain Management Market by Regions
1.4.1 Global Neuropathic Pain Management Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Neuropathic Pain Management Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Neuropathic Pain Management Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Neuropathic Pain Management Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Neuropathic Pain Management Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Neuropathic Pain Management Status and Prospect (2014-2024)
1.5 Global Market Size of Neuropathic Pain Management (2014-2024)
2 Company Profiles
2.1 Biogen Idec
2.1.1 Business Overview
2.1.2 Neuropathic Pain Management Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Biogen Idec Neuropathic Pain Management Revenue, Gross Margin and Market Share (2017-2018)
2.2 Baxter Healthcare Corporation
2.2.1 Business Overview
2.2.2 Neuropathic Pain Management Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Baxter Healthcare Corporation Neuropathic Pain Management Revenue, Gross Margin and Market Share (2017-2018)
2.3 GlaxoSmithKline
2.3.1 Business Overview
2.3.2 Neuropathic Pain Management Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 GlaxoSmithKline Neuropathic Pain Management Revenue, Gross Margin and Market Share (2017-2018)
2.4 Johnson & Johnson Services
2.4.1 Business Overview
2.4.2 Neuropathic Pain Management Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Johnson & Johnson Services Neuropathic Pain Management Revenue, Gross Margin and Market Share (2017-2018)
2.5 Pfizer
2.5.1 Business Overview
2.5.2 Neuropathic Pain Management Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Pfizer Neuropathic Pain Management Revenue, Gross Margin and Market Share (2017-2018)
2.6 Sanofi
2.6.1 Business Overview
2.6.2 Neuropathic Pain Management Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Sanofi Neuropathic Pain Management Revenue, Gross Margin and Market Share (2017-2018)
2.7 Bristol-Myers Squibb
2.7.1 Business Overview
2.7.2 Neuropathic Pain Management Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Bristol-Myers Squibb Neuropathic Pain Management Revenue, Gross Margin and Market Share (2017-2018)
2.8 Eli Lilly and Company
2.8.1 Business Overview
2.8.2 Neuropathic Pain Management Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Eli Lilly and Company Neuropathic Pain Management Revenue, Gross Margin and Market Share (2017-2018)
2.9 Depomed
2.9.1 Business Overview
2.9.2 Neuropathic Pain Management Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Depomed Neuropathic Pain Management Revenue, Gross Margin and Market Share (2017-2018)
3 Global Neuropathic Pain Management Market Competition, by Players
3.1 Global Neuropathic Pain Management Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Neuropathic Pain Management Players Market Share
3.2.2 Top 10 Neuropathic Pain Management Players Market Share
3.3 Market Competition Trend
4 Global Neuropathic Pain Management Market Size by Regions
4.1 Global Neuropathic Pain Management Revenue and Market Share by Regions
4.2 North America Neuropathic Pain Management Revenue and Growth Rate (2014-2019)
4.3 Europe Neuropathic Pain Management Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Neuropathic Pain Management Revenue and Growth Rate (2014-2019)
4.5 South America Neuropathic Pain Management Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Neuropathic Pain Management Revenue and Growth Rate (2014-2019)
5 North America Neuropathic Pain Management Revenue by Countries
5.1 North America Neuropathic Pain Management Revenue by Countries (2014-2019)
5.2 USA Neuropathic Pain Management Revenue and Growth Rate (2014-2019)
5.3 Canada Neuropathic Pain Management Revenue and Growth Rate (2014-2019)
5.4 Mexico Neuropathic Pain Management Revenue and Growth Rate (2014-2019)
6 Europe Neuropathic Pain Management Revenue by Countries
6.1 Europe Neuropathic Pain Management Revenue by Countries (2014-2019)
6.2 Germany Neuropathic Pain Management Revenue and Growth Rate (2014-2019)
6.3 UK Neuropathic Pain Management Revenue and Growth Rate (2014-2019)
6.4 France Neuropathic Pain Management Revenue and Growth Rate (2014-2019)
6.5 Russia Neuropathic Pain Management Revenue and Growth Rate (2014-2019)
6.6 Italy Neuropathic Pain Management Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Neuropathic Pain Management Revenue by Countries
7.1 Asia-Pacific Neuropathic Pain Management Revenue by Countries (2014-2019)
7.2 China Neuropathic Pain Management Revenue and Growth Rate (2014-2019)
7.3 Japan Neuropathic Pain Management Revenue and Growth Rate (2014-2019)
7.4 Korea Neuropathic Pain Management Revenue and Growth Rate (2014-2019)
7.5 India Neuropathic Pain Management Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Neuropathic Pain Management Revenue and Growth Rate (2014-2019)
8 South America Neuropathic Pain Management Revenue by Countries
8.1 South America Neuropathic Pain Management Revenue by Countries (2014-2019)
8.2 Brazil Neuropathic Pain Management Revenue and Growth Rate (2014-2019)
8.3 Argentina Neuropathic Pain Management Revenue and Growth Rate (2014-2019)
8.4 Colombia Neuropathic Pain Management Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Neuropathic Pain Management by Countries
9.1 Middle East and Africa Neuropathic Pain Management Revenue by Countries (2014-2019)
9.2 Saudi Arabia Neuropathic Pain Management Revenue and Growth Rate (2014-2019)
9.3 UAE Neuropathic Pain Management Revenue and Growth Rate (2014-2019)
9.4 Egypt Neuropathic Pain Management Revenue and Growth Rate (2014-2019)
9.5 Nigeria Neuropathic Pain Management Revenue and Growth Rate (2014-2019)
9.6 South Africa Neuropathic Pain Management Revenue and Growth Rate (2014-2019)
10 Global Neuropathic Pain Management Market Segment by Type
10.1 Global Neuropathic Pain Management Revenue and Market Share by Type (2014-2019)
10.2 Global Neuropathic Pain Management Market Forecast by Type (2019-2024)
10.3 Tricyclic Antidepressant Revenue Growth Rate (2014-2024)
10.4 Anticonvulsant Revenue Growth Rate (2014-2024)
10.5 Opioid Revenue Growth Rate (2014-2024)
10.6 Steroid Drug Revenue Growth Rate (2014-2024)
10.7 Local Anesthesia Revenue Growth Rate (2014-2024)
10.8 Other Revenue Growth Rate (2014-2024)
11 Global Neuropathic Pain Management Market Segment by Application
11.1 Global Neuropathic Pain Management Revenue Market Share by Application (2014-2019)
11.2 Neuropathic Pain Management Market Forecast by Application (2019-2024)
11.3 Retail Pharmacy Revenue Growth (2014-2019)
11.4 Hospital Pharmacy Revenue Growth (2014-2019)
11.5 Other Revenue Growth (2014-2019)
12 Global Neuropathic Pain Management Market Size Forecast (2019-2024)
12.1 Global Neuropathic Pain Management Market Size Forecast (2019-2024)
12.2 Global Neuropathic Pain Management Market Forecast by Regions (2019-2024)
12.3 North America Neuropathic Pain Management Revenue Market Forecast (2019-2024)
12.4 Europe Neuropathic Pain Management Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Neuropathic Pain Management Revenue Market Forecast (2019-2024)
12.6 South America Neuropathic Pain Management Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Neuropathic Pain Management Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source

List of Tables and Figures

Figure Neuropathic Pain Management Picture
Table Product Specifications of Neuropathic Pain Management
Table Global Neuropathic Pain Management and Revenue (Million USD) Market Split by Product Type
Figure Global Neuropathic Pain Management Revenue Market Share by Types in 2018
Figure Tricyclic Antidepressant Picture
Figure Anticonvulsant Picture
Figure Opioid Picture
Figure Steroid Drug Picture
Figure Local Anesthesia Picture
Figure Other Picture
Table Global Neuropathic Pain Management Revenue (Million USD) by Application (2014-2024)
Figure Neuropathic Pain Management Revenue Market Share by Applications in 2018
Figure Retail Pharmacy Picture
Figure Hospital Pharmacy Picture
Figure Other Picture
Table Global Market Neuropathic Pain Management Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Neuropathic Pain Management Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Neuropathic Pain Management Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Neuropathic Pain Management Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Neuropathic Pain Management Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Neuropathic Pain Management Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Neuropathic Pain Management Revenue (Million USD) and Growth Rate (2014-2024)
Table Biogen Idec Basic Information, Manufacturing Base and Competitors
Table Biogen Idec Neuropathic Pain Management Type and Applications
Table Biogen Idec Neuropathic Pain Management Revenue, Gross Margin and Market Share (2017-2018)
Table Baxter Healthcare Corporation Basic Information, Manufacturing Base and Competitors
Table Baxter Healthcare Corporation Neuropathic Pain Management Type and Applications
Table Baxter Healthcare Corporation Neuropathic Pain Management Revenue, Gross Margin and Market Share (2017-2018)
Table GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table GlaxoSmithKline Neuropathic Pain Management Type and Applications
Table GlaxoSmithKline Neuropathic Pain Management Revenue, Gross Margin and Market Share (2017-2018)
Table Johnson & Johnson Services Basic Information, Manufacturing Base and Competitors
Table Johnson & Johnson Services Neuropathic Pain Management Type and Applications
Table Johnson & Johnson Services Neuropathic Pain Management Revenue, Gross Margin and Market Share (2017-2018)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Neuropathic Pain Management Type and Applications
Table Pfizer Neuropathic Pain Management Revenue, Gross Margin and Market Share (2017-2018)
Table Sanofi Basic Information, Manufacturing Base and Competitors
Table Sanofi Neuropathic Pain Management Type and Applications
Table Sanofi Neuropathic Pain Management Revenue, Gross Margin and Market Share (2017-2018)
Table Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table Bristol-Myers Squibb Neuropathic Pain Management Type and Applications
Table Bristol-Myers Squibb Neuropathic Pain Management Revenue, Gross Margin and Market Share (2017-2018)
Table Eli Lilly and Company Basic Information, Manufacturing Base and Competitors
Table Eli Lilly and Company Neuropathic Pain Management Type and Applications
Table Eli Lilly and Company Neuropathic Pain Management Revenue, Gross Margin and Market Share (2017-2018)
Table Depomed Basic Information, Manufacturing Base and Competitors
Table Depomed Neuropathic Pain Management Type and Applications
Table Depomed Neuropathic Pain Management Revenue, Gross Margin and Market Share (2017-2018)
Table Global Neuropathic Pain Management Revenue (Million USD) by Players (2014-2019)
Table Global Neuropathic Pain Management Revenue Share by Players (2014-2019)
Figure Global Neuropathic Pain Management Revenue Share by Players in 2017
Figure Global Neuropathic Pain Management Revenue Share by Players in 2018
Figure Global Top 5 Players Neuropathic Pain Management Revenue Market Share in 2018
Figure Global Top 10 Players Neuropathic Pain Management Revenue Market Share in 2018
Figure Global Neuropathic Pain Management Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Neuropathic Pain Management Revenue (Million USD) by Regions (2014-2019)
Table Global Neuropathic Pain Management Revenue Market Share by Regions (2014-2019)
Figure Global Neuropathic Pain Management Revenue Market Share by Regions (2014-2019)
Figure Global Neuropathic Pain Management Revenue Market Share by Regions in 2018
Figure North America Neuropathic Pain Management Revenue and Growth Rate (2014-2019)
Figure Europe Neuropathic Pain Management Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Neuropathic Pain Management Revenue and Growth Rate (2014-2019)
Figure South America Neuropathic Pain Management Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Neuropathic Pain Management Revenue and Growth Rate (2014-2019)
Table North America Neuropathic Pain Management Revenue by Countries (2014-2019)
Table North America Neuropathic Pain Management Revenue Market Share by Countries (2014-2019)
Figure North America Neuropathic Pain Management Revenue Market Share by Countries (2014-2019)
Figure North America Neuropathic Pain Management Revenue Market Share by Countries in 2018
Figure USA Neuropathic Pain Management Revenue and Growth Rate (2014-2019)
Figure Canada Neuropathic Pain Management Revenue and Growth Rate (2014-2019)
Figure Mexico Neuropathic Pain Management Revenue and Growth Rate (2014-2019)
Table Europe Neuropathic Pain Management Revenue (Million USD) by Countries (2014-2019)
Figure Europe Neuropathic Pain Management Revenue Market Share by Countries (2014-2019)
Figure Europe Neuropathic Pain Management Revenue Market Share by Countries in 2018
Figure Germany Neuropathic Pain Management Revenue and Growth Rate (2014-2019)
Figure UK Neuropathic Pain Management Revenue and Growth Rate (2014-2019)
Figure France Neuropathic Pain Management Revenue and Growth Rate (2014-2019)
Figure Russia Neuropathic Pain Management Revenue and Growth Rate (2014-2019)
Figure Italy Neuropathic Pain Management Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Neuropathic Pain Management Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Neuropathic Pain Management Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Neuropathic Pain Management Revenue Market Share by Countries in 2018
Figure China Neuropathic Pain Management Revenue and Growth Rate (2014-2019)
Figure Japan Neuropathic Pain Management Revenue and Growth Rate (2014-2019)
Figure Korea Neuropathic Pain Management Revenue and Growth Rate (2014-2019)
Figure India Neuropathic Pain Management Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Neuropathic Pain Management Revenue and Growth Rate (2014-2019)
Table South America Neuropathic Pain Management Revenue by Countries (2014-2019)
Table South America Neuropathic Pain Management Revenue Market Share by Countries (2014-2019)
Figure South America Neuropathic Pain Management Revenue Market Share by Countries (2014-2019)
Figure South America Neuropathic Pain Management Revenue Market Share by Countries in 2018
Figure Brazil Neuropathic Pain Management Revenue and Growth Rate (2014-2019)
Figure Argentina Neuropathic Pain Management Revenue and Growth Rate (2014-2019)
Figure Colombia Neuropathic Pain Management Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Neuropathic Pain Management Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Neuropathic Pain Management Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Neuropathic Pain Management Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Neuropathic Pain Management Revenue Market Share by Countries in 2018
Figure Saudi Arabia Neuropathic Pain Management Revenue and Growth Rate (2014-2019)
Figure UAE Neuropathic Pain Management Revenue and Growth Rate (2014-2019)
Figure Egypt Neuropathic Pain Management Revenue and Growth Rate (2014-2019)
Figure Nigeria Neuropathic Pain Management Revenue and Growth Rate (2014-2019)
Figure South Africa Neuropathic Pain Management Revenue and Growth Rate (2014-2019)
Table Global Neuropathic Pain Management Revenue (Million USD) by Type (2014-2019)
Table Global Neuropathic Pain Management Revenue Share by Type (2014-2019)
Figure Global Neuropathic Pain Management Revenue Share by Type (2014-2019)
Figure Global Neuropathic Pain Management Revenue Share by Type in 2018
Table Global Neuropathic Pain Management Revenue Forecast by Type (2019-2024)
Figure Global Neuropathic Pain Management Market Share Forecast by Type (2019-2024)
Figure Global Tricyclic Antidepressant Revenue Growth Rate (2014-2019)
Figure Global Anticonvulsant Revenue Growth Rate (2014-2019)
Figure Global Opioid Revenue Growth Rate (2014-2019)
Figure Global Steroid Drug Revenue Growth Rate (2014-2019)
Figure Global Local Anesthesia Revenue Growth Rate (2014-2019)
Figure Global Other Revenue Growth Rate (2014-2019)
Table Global Neuropathic Pain Management Revenue by Application (2014-2019)
Table Global Neuropathic Pain Management Revenue Share by Application (2014-2019)
Figure Global Neuropathic Pain Management Revenue Share by Application (2014-2019)
Figure Global Neuropathic Pain Management Revenue Share by Application in 2018
Table Global Neuropathic Pain Management Revenue Forecast by Application (2019-2024)
Figure Global Neuropathic Pain Management Market Share Forecast by Application (2019-2024)
Figure Global Retail Pharmacy Revenue Growth Rate (2014-2019)
Figure Global Hospital Pharmacy Revenue Growth Rate (2014-2019)
Figure Global Other Revenue Growth Rate (2014-2019)
Figure Global Neuropathic Pain Management Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Neuropathic Pain Management Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Neuropathic Pain Management Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Neuropathic Pain Management Revenue Market Forecast (2019-2024)
Figure Europe Neuropathic Pain Management Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Neuropathic Pain Management Revenue Market Forecast (2019-2024)
Figure South America Neuropathic Pain Management Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Neuropathic Pain Management Revenue Market Forecast (2019-2024)